Corpus a/lenvervimab

Lenvervimab

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Cite
APA 7MLA 9ChicagoHarvardIEEEBibTeXRISCSL-JSON
Export
MarkdownTextJSONCSVCard (SVG)PDFCard (PNG)
Learn
Lesson planQuizBibliography

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Lenvervimab (INN; development code GC1102) is a monoclonal antibody that is being investigated for hepatitis B. This drug is being developed by GC Pharma. , lenvervimab is undergoing Phase II/III trials.

Lenvervimab (INN; development code GC1102) is a monoclonal antibody that is being investigated for hepatitis B. This drug is being developed by GC Pharma. , lenvervimab is undergoing Phase II/III trials.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1330056264 under CC BY-SA 4.0; modifications have been made.